Contact
searchSearch
HMP Global

Drug Recalls Topic Center

The Latest

News
Rising Pharma Recalls Lot of Temozolomide Capsules Following Impurities Concern
03/05/2026
Grace Taylor, MS, MA
Rising Pharma has voluntarily recalled one nationwide lot of temozolomide 5 mg capsules after stability testing revealed out-of-specification impurities results.
Rising Pharma has voluntarily recalled one nationwide lot of temozolomide 5 mg capsules after stability testing revealed out-of-specification impurities results.
Rising Pharma has voluntarily...
03/05/2026
Pharmacy Learning Network
News
Lidocaine/Racepinephrine Spray Recalled Over Expiration Date Issues
03/05/2026
Grace Taylor, MS, MA
HTO Nevada has voluntarily recalled more than 27 000 bottles of Five-Star Vasocaine Spray nationwide after determining that stability data do not support the product’s labeled expiration dates.
HTO Nevada has voluntarily recalled more than 27 000 bottles of Five-Star Vasocaine Spray nationwide after determining that stability data do not support the product’s labeled expiration dates.
HTO Nevada has voluntarily...
03/05/2026
Pharmacy Learning Network
News
Nationwide Recall of Isotretinoin Capsules Issued Over Dissolution Failure
03/05/2026
Grace Taylor, MS, MA
Mylan Pharmaceuticals has voluntarily recalled select lots of isotretinoin 40 mg capsules distributed nationwide after the product failed to meet dissolution specifications.
Mylan Pharmaceuticals has voluntarily recalled select lots of isotretinoin 40 mg capsules distributed nationwide after the product failed to meet dissolution specifications.
Mylan Pharmaceuticals has...
03/05/2026
Pharmacy Learning Network
News
Recall of BioGlo Fluorescein Sodium Strips Cites Manufacturing Compliance Concerns
02/26/2026
Grace Taylor, MS, MA
More than 184 000 containers of BioGlo Fluorescein Sodium Ophthalmic Strips are being recalled nationwide after the US Food and Drug Administration (FDA) cited manufacturing lapses leading to a lack of sterility assurance.
More than 184 000 containers of BioGlo Fluorescein Sodium Ophthalmic Strips are being recalled nationwide after the US Food and Drug Administration (FDA) cited manufacturing lapses leading to a lack of sterility assurance.
More than 184 000 containers of...
02/26/2026
Pharmacy Learning Network
News
FDA Class II Recall Issued for Tralokinumab-ldrm Injection Over Sterility Concern
02/26/2026
Grace Taylor, MS, MA
LEO Pharma has voluntarily recalled select lots of Adbry (tralokinumab-ldrm) injection after particulate matter identified as wool fiber raised concerns about sterility in distributed autoinjector units.
LEO Pharma has voluntarily recalled select lots of Adbry (tralokinumab-ldrm) injection after particulate matter identified as wool fiber raised concerns about sterility in distributed autoinjector units.
LEO Pharma has voluntarily...
02/26/2026
Pharmacy Learning Network
News
Slate Run Pharmaceuticals Recalls Eptifibatide Injection Nationwide Over Carton Labeling Error
02/26/2026
Grace Taylor, MS, MA
Slate Run Pharmaceuticals has initiated a nationwide Class III recall of eptifibatide injection after discovering a labeling error that incorrectly describes the product’s dosing instructions.
Slate Run Pharmaceuticals has initiated a nationwide Class III recall of eptifibatide injection after discovering a labeling error that incorrectly describes the product’s dosing instructions.
Slate Run Pharmaceuticals has...
02/26/2026
Pharmacy Learning Network
News
Thiamine HCl Sodium Chloride Injection Recalled for Lack of Sterility Assurance
02/19/2026
Hannah Musick
A Class II recall for thiamine HCl 500 mg in 0.9% Sodium Chloride Injection has been issued due to a lack of sterility assurance, affecting more than 10 000 IV bags distributed nationwide.
A Class II recall for thiamine HCl 500 mg in 0.9% Sodium Chloride Injection has been issued due to a lack of sterility assurance, affecting more than 10 000 IV bags distributed nationwide.
A Class II recall for thiamine...
02/19/2026
Pharmacy Learning Network
News
FDA Class II Recall Issued for Oxycodone Hydrochloride
02/19/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for oxycodone hydrochloride tablets after reports of defective blister packaging seals, raising concerns about dose loss and controlled substance accountability.
The US Food and Drug Administration (FDA) has issued a Class II recall for oxycodone hydrochloride tablets after reports of defective blister packaging seals, raising concerns about dose loss and controlled substance accountability.
The US Food and Drug...
02/19/2026
Pharmacy Learning Network
News
Doxazosin Tablets Recalled Due to Incorrect Tablet Imprint
02/12/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class III recall for doxazosin tablets after a manufacturing error resulted in tablets imprinted with the wrong identifier.
The US Food and Drug Administration (FDA) has issued a Class III recall for doxazosin tablets after a manufacturing error resulted in tablets imprinted with the wrong identifier.
The US Food and Drug...
02/12/2026
Pharmacy Learning Network
News
Testosterone Pellets Recalled Over Potential Contamination
02/12/2026
Hannah Musick
A Class II recall has been issued for multiple lots of testosterone and combination hormone pellets due to the potential presence of particulate matter in implantable hormone therapy products distributed nationwide.
A Class II recall has been issued for multiple lots of testosterone and combination hormone pellets due to the potential presence of particulate matter in implantable hormone therapy products distributed nationwide.
A Class II recall has been...
02/12/2026
Pharmacy Learning Network
News
Asteria Health Estradiol Pellets Recalled Over Potential Metal Contamination
02/12/2026
Hannah Musick
A Class II recall for Asteria Health estradiol sterile pellets has been issued due to the potential presence of metal particulate matter, affecting multiple strengths and lots used in hormone replacement therapy.
A Class II recall for Asteria Health estradiol sterile pellets has been issued due to the potential presence of metal particulate matter, affecting multiple strengths and lots used in hormone replacement therapy.
A Class II recall for Asteria...
02/12/2026
Pharmacy Learning Network

Newsfeed

News
Rising Pharma Recalls Lot of Temozolomide Capsules Following Impurities Concern
03/05/2026
Grace Taylor, MS, MA
Rising Pharma has voluntarily recalled one nationwide lot of temozolomide 5 mg capsules after stability testing revealed out-of-specification impurities results.
Rising Pharma has voluntarily recalled one nationwide lot of temozolomide 5 mg capsules after stability testing revealed out-of-specification impurities results.
Rising Pharma has voluntarily...
03/05/2026
Pharmacy Learning Network
News
Lidocaine/Racepinephrine Spray Recalled Over Expiration Date Issues
03/05/2026
Grace Taylor, MS, MA
HTO Nevada has voluntarily recalled more than 27 000 bottles of Five-Star Vasocaine Spray nationwide after determining that stability data do not support the product’s labeled expiration dates.
HTO Nevada has voluntarily recalled more than 27 000 bottles of Five-Star Vasocaine Spray nationwide after determining that stability data do not support the product’s labeled expiration dates.
HTO Nevada has voluntarily...
03/05/2026
Pharmacy Learning Network
News
Nationwide Recall of Isotretinoin Capsules Issued Over Dissolution Failure
03/05/2026
Grace Taylor, MS, MA
Mylan Pharmaceuticals has voluntarily recalled select lots of isotretinoin 40 mg capsules distributed nationwide after the product failed to meet dissolution specifications.
Mylan Pharmaceuticals has voluntarily recalled select lots of isotretinoin 40 mg capsules distributed nationwide after the product failed to meet dissolution specifications.
Mylan Pharmaceuticals has...
03/05/2026
Pharmacy Learning Network
News
Slate Run Pharmaceuticals Recalls Eptifibatide Injection Nationwide Over Carton Labeling Error
02/26/2026
Grace Taylor, MS, MA
Slate Run Pharmaceuticals has initiated a nationwide Class III recall of eptifibatide injection after discovering a labeling error that incorrectly describes the product’s dosing instructions.
Slate Run Pharmaceuticals has initiated a nationwide Class III recall of eptifibatide injection after discovering a labeling error that incorrectly describes the product’s dosing instructions.
Slate Run Pharmaceuticals has...
02/26/2026
Pharmacy Learning Network
News
Thiamine HCl Sodium Chloride Injection Recalled for Lack of Sterility Assurance
02/19/2026
Hannah Musick
A Class II recall for thiamine HCl 500 mg in 0.9% Sodium Chloride Injection has been issued due to a lack of sterility assurance, affecting more than 10 000 IV bags distributed nationwide.
A Class II recall for thiamine HCl 500 mg in 0.9% Sodium Chloride Injection has been issued due to a lack of sterility assurance, affecting more than 10 000 IV bags distributed nationwide.
A Class II recall for thiamine...
02/19/2026
Pharmacy Learning Network
News
FDA Class II Recall Issued for Oxycodone Hydrochloride
02/19/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for oxycodone hydrochloride tablets after reports of defective blister packaging seals, raising concerns about dose loss and controlled substance accountability.
The US Food and Drug Administration (FDA) has issued a Class II recall for oxycodone hydrochloride tablets after reports of defective blister packaging seals, raising concerns about dose loss and controlled substance accountability.
The US Food and Drug...
02/19/2026
Pharmacy Learning Network
News
Doxazosin Tablets Recalled Due to Incorrect Tablet Imprint
02/12/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class III recall for doxazosin tablets after a manufacturing error resulted in tablets imprinted with the wrong identifier.
The US Food and Drug Administration (FDA) has issued a Class III recall for doxazosin tablets after a manufacturing error resulted in tablets imprinted with the wrong identifier.
The US Food and Drug...
02/12/2026
Pharmacy Learning Network
News
Asteria Health Estradiol Pellets Recalled Over Potential Metal Contamination
02/12/2026
Hannah Musick
A Class II recall for Asteria Health estradiol sterile pellets has been issued due to the potential presence of metal particulate matter, affecting multiple strengths and lots used in hormone replacement therapy.
A Class II recall for Asteria Health estradiol sterile pellets has been issued due to the potential presence of metal particulate matter, affecting multiple strengths and lots used in hormone replacement therapy.
A Class II recall for Asteria...
02/12/2026
Pharmacy Learning Network
News
Recall Issued for Parodontax Active Gum Health Mouthwash Due to Labeling Error
02/05/2026
Grace Taylor, MS, MA
A voluntary Class III recall has been issued for parodontax Active Gum Health Mouthwash after discovering that some bottles may be missing or have illegible lot and expiration date information.
A voluntary Class III recall has been issued for parodontax Active Gum Health Mouthwash after discovering that some bottles may be missing or have illegible lot and expiration date information.
A voluntary Class III recall has...
02/05/2026
Pharmacy Learning Network
News
Antacid Tablets Recalled Due to Failed Disintegration Specifications
01/29/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for INON ACE Antacid Tablets due to failed disintegration specifications, which may reduce the product’s effectiveness in relieving indigestion and gas.
The US Food and Drug Administration (FDA) has issued a Class II recall for INON ACE Antacid Tablets due to failed disintegration specifications, which may reduce the product’s effectiveness in relieving indigestion and gas.
The US Food and Drug...
01/29/2026
Pharmacy Learning Network
News
Rising Pharma Recalls Lot of Temozolomide Capsules Following Impurities Concern
03/05/2026
Grace Taylor, MS, MA
Rising Pharma has voluntarily recalled one nationwide lot of temozolomide 5 mg capsules after stability testing revealed out-of-specification impurities results.
Rising Pharma has voluntarily recalled one nationwide lot of temozolomide 5 mg capsules after stability testing revealed out-of-specification impurities results.
Rising Pharma has voluntarily...
03/05/2026
Pharmacy Learning Network
News
Lidocaine/Racepinephrine Spray Recalled Over Expiration Date Issues
03/05/2026
Grace Taylor, MS, MA
HTO Nevada has voluntarily recalled more than 27 000 bottles of Five-Star Vasocaine Spray nationwide after determining that stability data do not support the product’s labeled expiration dates.
HTO Nevada has voluntarily recalled more than 27 000 bottles of Five-Star Vasocaine Spray nationwide after determining that stability data do not support the product’s labeled expiration dates.
HTO Nevada has voluntarily...
03/05/2026
Pharmacy Learning Network
News
Nationwide Recall of Isotretinoin Capsules Issued Over Dissolution Failure
03/05/2026
Grace Taylor, MS, MA
Mylan Pharmaceuticals has voluntarily recalled select lots of isotretinoin 40 mg capsules distributed nationwide after the product failed to meet dissolution specifications.
Mylan Pharmaceuticals has voluntarily recalled select lots of isotretinoin 40 mg capsules distributed nationwide after the product failed to meet dissolution specifications.
Mylan Pharmaceuticals has...
03/05/2026
Pharmacy Learning Network
PharmLaw
Louisiana Secures $45M Settlement With CVS, Caremark Over PBM Practices
03/04/2026
Grace Taylor, MS, MA
Louisiana secured a $45 million settlement from CVS and its pharmacy benefit manager (PBM) affiliate following lawsuits alleging deceptive practices, misuse of patient data, and anti-competitive conduct affecting independent pharmacies.
Louisiana secured a $45 million settlement from CVS and its pharmacy benefit manager (PBM) affiliate following lawsuits alleging deceptive practices, misuse of patient data, and anti-competitive conduct affecting independent pharmacies.
Louisiana secured a $45 million...
03/04/2026
Pharmacy Learning Network
PharmLaw
Federal Court Preliminarily Approves $5.275M Settlement in PharMerica Data Breach Class Action
02/27/2026
Grace Taylor, MS, MA
A federal judge has preliminarily approved a $5.275 million nationwide settlement resolving claims that PharMerica failed to safeguard patient data in a 2023 ransomware attack.
A federal judge has preliminarily approved a $5.275 million nationwide settlement resolving claims that PharMerica failed to safeguard patient data in a 2023 ransomware attack.
A federal judge has...
02/27/2026
Pharmacy Learning Network
News
Slate Run Pharmaceuticals Recalls Eptifibatide Injection Nationwide Over Carton Labeling Error
02/26/2026
Grace Taylor, MS, MA
Slate Run Pharmaceuticals has initiated a nationwide Class III recall of eptifibatide injection after discovering a labeling error that incorrectly describes the product’s dosing instructions.
Slate Run Pharmaceuticals has initiated a nationwide Class III recall of eptifibatide injection after discovering a labeling error that incorrectly describes the product’s dosing instructions.
Slate Run Pharmaceuticals has...
02/26/2026
Pharmacy Learning Network
PharmLaw
Physician Sentenced in $145 Million Compound Cream Kickback Scheme Involving DOL-OWCP Billing
02/25/2026
Grace Taylor, MS, MA
A Texas physician was sentenced to prison for accepting kickbacks tied to medically unnecessary compounded creams billed to the US Department of Labor’s Office of Workers’ Compensation Programs (DOL-OWCP) and private insurers.
A Texas physician was sentenced to prison for accepting kickbacks tied to medically unnecessary compounded creams billed to the US Department of Labor’s Office of Workers’ Compensation Programs (DOL-OWCP) and private insurers.
A Texas physician was sentenced...
02/25/2026
Pharmacy Learning Network
News
Thiamine HCl Sodium Chloride Injection Recalled for Lack of Sterility Assurance
02/19/2026
Hannah Musick
A Class II recall for thiamine HCl 500 mg in 0.9% Sodium Chloride Injection has been issued due to a lack of sterility assurance, affecting more than 10 000 IV bags distributed nationwide.
A Class II recall for thiamine HCl 500 mg in 0.9% Sodium Chloride Injection has been issued due to a lack of sterility assurance, affecting more than 10 000 IV bags distributed nationwide.
A Class II recall for thiamine...
02/19/2026
Pharmacy Learning Network
News
FDA Class II Recall Issued for Oxycodone Hydrochloride
02/19/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for oxycodone hydrochloride tablets after reports of defective blister packaging seals, raising concerns about dose loss and controlled substance accountability.
The US Food and Drug Administration (FDA) has issued a Class II recall for oxycodone hydrochloride tablets after reports of defective blister packaging seals, raising concerns about dose loss and controlled substance accountability.
The US Food and Drug...
02/19/2026
Pharmacy Learning Network
PharmLaw
Atlantic Biologicals Enters Deferred Prosecution Agreement in Opioid Distribution Scheme
02/18/2026
Hannah Musick
Atlantic Biologicals Corporation has entered a 2-year deferred prosecution agreement after admitting its business unit sold more than 14 million opioid doses to Houston-area pill mill pharmacies, generating over $2.5 million in gross proceeds.
Atlantic Biologicals Corporation has entered a 2-year deferred prosecution agreement after admitting its business unit sold more than 14 million opioid doses to Houston-area pill mill pharmacies, generating over $2.5 million in gross proceeds.
Atlantic Biologicals Corporation...
02/18/2026
Pharmacy Learning Network

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use